This inventor holds 6 USPTO granted patents, plus 1 CIPO patent and 4 EPO patents. Top assignees: Senju Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Nippon Chemiphar Co., Ltd.. Active years: 2009-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kobe, JP (2009 - 2015)
- Hyogo, JP (2016)
Company Filing History:

Years Active: 2009-2016
Title: Innovations by Yoshikuni Nakamura
Introduction
Yoshikuni Nakamura is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of ocular diseases. With a total of 6 patents to his name, his work has had a considerable impact on medical science.
Latest Patents
Nakamura's latest patents include a pharmaceutical formulation containing a PPAR-delta agonist. This preparation is designed to promote the proliferation of meibomian gland epithelial cells and corneal epithelial cells. It serves as a therapeutic agent for ocular diseases such as meibomian gland dysfunction and dry eye. Another significant patent involves a pharmaceutical comprising a PPAR agonist, aimed at treating similar ocular conditions. These innovations highlight his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Yoshikuni Nakamura has worked with prominent companies in the pharmaceutical industry. Notable among these are Senju Pharmaceutical Co., Ltd. and Mitsubishi Tanabe Pharma Corporation. His experience in these organizations has contributed to his expertise and success as an inventor.
Collaborations
Nakamura has collaborated with several professionals in his field, including Jun Inoue and Ikuko Hanano. These partnerships have likely enriched his research and development efforts, leading to innovative solutions in pharmaceuticals.
Conclusion
Yoshikuni Nakamura's contributions to the pharmaceutical industry, particularly in ocular health, demonstrate his innovative spirit and dedication to improving medical treatments. His patents reflect a deep understanding of the complexities of ocular diseases and a commitment to finding effective solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile